Tango Therapeutics

TNGX • NASDAQ • Stock Fundamentals

Tango Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Malte Peters, with a market cap of $4.3B.

Market Cap$4.3B

Employees140.0

CEOMalte Peters

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 1 month 1 day agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Tango Therapeutics

Tango Therapeutics (TNGX) has a market capitalization of $4.3B and trades on NASDAQ.

Tango Therapeutics has approximately 140 employees.